USFDA classifies Sun Pharmaceutical Halol facility as OAI
USFDA classifies Sun Pharmaceutical Halol facility as OAI

USFDA classifies Sun Pharmaceutical Halol facility as OAI

Apurva Joshi Article rating: 5.0

On December 13, 2019, Sun Pharmaceutical had informed that USFDA’s inspection at the company’s Halol (Gujarat) facility from December 3 to 13, 2019 had led to the issuance of form 483 by USFDA with eight observations.

L&T to donate Rs 150 crore in PM-CARES fund
L&T to donate Rs 150 crore in PM-CARES fund

L&T to donate Rs 150 crore in PM-CARES fund

Rishikesh Gaikwad Article rating: 3.9

Larsen & Toubro, India’s leading technology, engineering, construction, manufacturing and financial services conglomerate, is committed to participate in corporate India’s response to COVID-19 through funds, community welfare plans and by leveraging its expertise to offer assistance. 

Strides Pharma gets another EIR for Bengaluru facility
Strides Pharma gets another EIR for Bengaluru facility

Strides Pharma gets another EIR for Bengaluru facility

Apurva Joshi Article rating: 4.3

Strides Pharma Science Limited has received an establishment inspection report (EIR) for the inspection conducted by United States Food & Drug Administration (USFDA) in January 2020 at its flagship facility (KRS Gardens) in Bengaluru thereby, confirming the successful closure of the inspections.

COVID-19: TVS & Sundaram Clayton pitch in Rs 30 crore
COVID-19: TVS & Sundaram Clayton pitch in Rs 30 crore

COVID-19: TVS & Sundaram Clayton pitch in Rs 30 crore

Geyatee Deshpande Article rating: 3.8

TVS Motor Company, which is a two-wheeler and three-wheeler manufacturer, along with die-caster Sundaram-Clayton Ltd (SCL), together announced spending of around Rs 30 crore for supporting the efforts to curb the spread of COVID-19.

Five stocks with buying interest
Five stocks with buying interest

Five stocks with buying interest

Abhishek Kapoor Article rating: 4.1

The market opened in the red on March 30, 2020, overall volumes in futures & options currently stand at 77.45 lakh contracts with a turnover of Rs. 4,29,040.68 crore.

Five stocks with selling interest
Five stocks with selling interest

Five stocks with selling interest

Abhishek Kapoor Article rating: 4.8

The market opened in the red on March 30, 2020, overall volumes in futures & options currently stand at 77.45 lakh contracts with a turnover of Rs. 4,29,040.68 crore.

Stocks close to their 52-week high
Stocks close to their 52-week high

Stocks close to their 52-week high

Abhishek Kapoor Article rating: 4.3

The market opened in the red on March 30, 2020. The previous trading session witnessed the Sensex going down by 131.18 points to end at 29,815.59 and the Nifty was up 18.80 points to close at 8,660.25.

Ten stocks close to their 52-week low
Ten stocks close to their 52-week low

Ten stocks close to their 52-week low

Abhishek Kapoor Article rating: 3.9

The market opened in the red on March 30, 2020. The previous trading session witnessed the Sensex going down by 131.18 points to end at 29,815.59 and the Nifty was up 18.80 points to close at 8,660.25.

Index trend and stocks in action on March 30, 2020
Index trend and stocks in action on March 30, 2020

Index trend and stocks in action on March 30, 2020

Karan Dsij Article rating: 5.0

The high to low range of the last week becomes crucial which stands at 7,511 to 9,039 levels. As long as we stay within this range, we can expect the markets to consolidate. Stocks in news: Sun Pharmaceutical, Motherson Sumi systems, Manappuram Finance, NTPC, Delta Corp, Lupin and Laurus Labs.

Be ready for the bear attack!
Be ready for the bear attack!

Be ready for the bear attack!

Karan Dsij Article rating: 2.5

Welcome to the fresh week on D-Street! The markets ended the last trading session near the day’s low and gave away the entire decent gains post RBI announcement. Over the weekend, if market participants were hoping for some Monday Magic to revive the sentiments on D-Street, which lost its pace after RBI announcement then, they will be certainly disappointed.

RSS
First28492850285128522854285628572858Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR